Ireland
--:--IST
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Kłodzko
Clinical trial register · Poland

Clinical Trials in Kłodzko, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2680 matching records held by the registry are in this view. Synced 01 Oct 2026, 03:17 UTC
2680
Studies in scope
all four open statuses
1393
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Warsaw 1298 Krakow 874 Poznan 697 Gdansk 655 Lodz 623
Narrow the registerReset
Recruitment status
Phase
Site location
Warsaw1298 Krakow874 Poznan697 Gdansk655 Lodz623
All 260 locations
Target enrolment
to

Trials with a site in Kłodzko

9 of 2680 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07845487Ulcerative Colitis (UC), Severe Ulcerative Colitis, Moderate Ulcerative Colitis
Palisade Bio
Phase 2
204
Bydgoszcz, Elblag, Katowice, Kielce, Krakow, Kłodzko, Lodz, Lublin
2026-08-28
By invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
NCT07652294Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
Spyre Therapeutics, Inc.
Phase 2
645
Bydgoszcz, Kłodzko, Opole, Poznan, Rzeszów, Sopot, Szczecin, Tychy
2026-06-08
Recruiting
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
NCT07184944Crohn's Disease
Sanofi
Phase 3
751
Bydgoszcz, Kłodzko, Lublin, Staszów, Szczecin, Warsaw
2026-01-22
Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
NCT07184931Crohn's Disease
Sanofi
Phase 3
980
Bydgoszcz, Elblag, Katowice, Krakow, Kłodzko, Lodz, Lublin, Nowy Targ
2025-10-01
Active, closed
C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV
NCT07037277HEPATITIS C VIRUS CHRONIC INFECTION, Hepatitis C, Chronic, Hepatitis C Virus Infection, Hepatitis C
Atea Pharmaceuticals, Inc.
Phase 3
880
Krakow, Kłodzko, Lublin, Mysłowice, Warsaw, Wroclaw
2025-06-02
Active, closed
Study of the Safety and Immunogenicity of Catch-up Vaccination With a 21-valent Pneumococcal Conjugate Vaccine (PCV21) in Healthy Infants, Toddlers, Children, and Adolescents
NCT06838000Pneumococcal Infections
Sanofi Pasteur, a Sanofi Company
Phase 3
1,268
Lodz, Warsaw, Częstochowa, Bydgoszcz, Kłodzko, Torun
2025-02-28
Active, closed
A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis
NCT06550076Plaque Psoriasis
Takeda
Phase 3
2,099
Poznan, Krakow, Katowice, Kłodzko, Wroclaw, Lublin, Lódz, Nadarzyn
2024-09-04
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
NCT06226883Inflammatory Bowel Diseases, Crohn's Disease
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
385
Bydgoszcz, Częstochowa, Elblag, Gdansk, Katowice, Krakow, Kłodzko, Opole
2024-07-18
Active, closed
A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
NCT05668013Crohn Disease, Colitis, Ulcerative
Teva Branded Pharmaceutical Products R&D LLC
Phase 2
247
Bydgoszcz, Częstochowa, Elblag, Gdansk, Katowice, Krakow, Kłodzko, Lodz
2023-01-11
Rows per page Showing 1–9 of 9
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 2 October 2026. https://priyalifescience.com/clinical-trials-poland/city/k-odzko

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,680 studies in total at the last sync on 01 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 9 of those studies with a site in Kłodzko.

How many clinical trials are recruiting in Kłodzko?

4 of the 9 studies on this page are recruiting new participants as of the 01 Oct 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 4 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Kłodzko), 9 studies
PhaseStudiesRecruitingShare
Phase 35255.6%
Phase 24244.4%

Most active sponsors

Lead sponsors with the most studies (Kłodzko)
Lead sponsorStudiesRecruiting
Sanofi22
Atea Pharmaceuticals, Inc.10
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)11
Palisade Bio11
Sanofi Pasteur, a Sanofi Company10
Spyre Therapeutics, Inc.10
Takeda10
Teva Branded Pharmaceutical Products R&D LLC10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.